Company: NGVT
Filing Date: 2025-03-12
Form Type: DEFA14A
Source: 0001140361-25-008443
Chunk: 4

Company: Ingevity Corp
Filing Date: 2025-03-12
Form: DEFA14A
Chunk 4
---
 as managing director at PPG Russia, where he drove an increase in profitable growth for the multiple coatings businesses. Earlier in his career, he held roles at various premier specialty chemicals multinationals including Solvay Group, Dow Chemical Company and Rohm and Hass. His approach to team building and strengthening employee engagement by empowering teams to take ownership and drive innovation aligns with our IngeviWay in Action values and makes Michael well suited to lead our talented team and drive the next phase of growth for APT. Michael holds a master of arts in German and French from the University of Oxford, Wadham College, and a master of business administration from London Business School. He currently resides in London and will be relocating to the Warrington area. Reporting to Michael will be Joel Neale, Global Commercial Director; Paul Shelley, Plant Manager; and Steve Monaghan, Marketing Director and Innovation Director. Please join me in wishing Michael the best of luck in his new role, and as always, please work safely and stay healthy. Best regards, Luis Fernandez-Moreno Interim President and CEO Additional Information and Where to Find It In connection with Ingevity’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), Ingevity filed on March 10, 2025with the Securities and Exchange Commission (“SEC”) a preliminary proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of WHITE proxy card. The Proxy Statement is in preliminary form and Ingevity intends to file and mail to stockholders of record entitled to vote at the 2025 Annual Meeting a definitive proxy statement and other documents, including a WHITE proxy card. This communication is not a substitute for any proxy statement or other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC’s website at http://www.sec.gov and at Ingev